Chief Scientific Officer Stephen Betz of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) sold 3,000 shares of the company on January 10, 2024, according to a recent SEC Filing.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Crinetics Pharmaceuticals Inc Insider Sells Shares